BCI is translating the breakthrough fundamental scientific discoveries of its founders into clinical and commercial programs for treatment of CNS disorders.

BCI is focusing its initial efforts on acquiring clinical stage assets that can be rapidly developed with low risk profiles for the treatment of CNS indications. BCI plans to work in partnership with other biopharmaceutical companies to apply its platform in the earlier stages of drug development.

Diagram